India atorvastatin market is expected to
grow at a steady rate during the forecast period. The India atorvastatin market
is driven by the surging use of this class of drugs for treating cardiovascular
diseases in the country such as atherosclerosis, heart attack, angina, stroke,
etc. In addition to this, it is used as protective agent for myocardial
infarction, revascularization in patients with type 2 diabetes without coronary
heart disease but with multiple risk factors. Along with this, supportive
government policies and schemes for promoting the development of drugs,
intermediates and active pharmaceutical ingredients in the country are further
anticipated to bode well for the market growth.
The India atorvastatin market is
segmented based on source, form, distribution channel, application, company and
region. Based on application, the market can be split into hypercholesterolemia,
hypertriglyceridemia, dyslipidaemia and others. The hypercholesterolemia is
expected to dominate the market owing to rising incidence of
hypercholesterolemia in the country. Based on distribution channel, the market
is split into online v/s offline. Out of which, the online segment is also
expected to register significant growth over the next few years. This can be
ascribed to the emergence of several online pharmacies and doorstep drug
delivery e-commerce platforms in the country.
The major players operating in the India
atorvastatin market are Jubilant Life Sciences Ltd., Dr. Reddy’s Laboratories
Ltd., Sun Pharmaceutical Industries Ltd., Ind-Swift Labs Ltd., Morepen
Laboratories Ltd., Anuh Pharma Ltd., Cadila Pharmaceuticals Ltd., Pfizer
Limited, Teva API India Limited, Lupin Limited and others. Major companies are
developing advanced technologies, receiving approvals from regulatory bodies
and launching new products in order to stay competitive in the market. For
Instance, the U.S. FDA granted license to Morepen Laboratories to manufacture
atorvastatin calcium for export to the U.S., thus strengthening the market
position.
Years
considered for this report:
Historical Years: FY2016-FY2019
Base Year: FY2020
Estimated Year: FY2021
Forecast Period: FY2022–FY2026
Objective of the Study:
- To analyze and estimate the market size of India atorvastatin market
from FY2016 to FY2019.
- To estimate and forecast the market size of India atorvastatin market
from FY2020 to FY2026 and growth rate until FY2026.
- To classify and forecast India atorvastatin market based on source,
form, distribution channel, application, company and regional
distribution.
- To identify dominant region or segment in the India atorvastatin market.
- To identify drivers and challenges for India atorvastatin market.
- To examine competitive developments such as expansions, new product
launches, mergers & acquisitions, etc., in India atorvastatin market.
- To identify and analyze the profile of leading players operating in
India atorvastatin market.
- To identify key sustainable strategies adopted by market players in
India atorvastatin market.
Click here to download the sample
TechSci Research performed both primary as well as exhaustive
secondary research for this study. Initially, TechSci Research sourced a list
of manufacturers across the globe. Subsequently, TechSci Research conducted
primary research surveys with the identified companies. While interviewing, the
respondents were also enquired about their competitors. Through this technique,
TechSci Research could include the manufacturers which could not be identified
due to the limitations of secondary research. TechSci Research analyzed the
manufacturers, distribution channels and presence of all major players across
the globe.
TechSci
Research calculated the market size of India atorvastatin market using a bottom-up approach, wherein data for various end-user segments
was recorded and forecast for the future years. TechSci Research sourced these
values from the industry experts and company representatives and externally
validated through analyzing historical data of these product types and
applications for getting an appropriate, overall market size. Various secondary
sources such as company websites, news articles, press releases, company annual
reports, investor presentations and financial reports were also studied by
TechSci Research.
Key Target Audience:
- Atorvastatin manufacturers/ suppliers/
distributors
- Market research and consulting firms
- Government bodies such as regulating
authorities and policy makers
- Organizations, forums and alliances related to
atorvastatin
The study is useful in providing answers to several critical
questions that are important for the industry stakeholders such as manufacturers,
suppliers and partners, end users, etc., besides allowing them in strategizing
investments and capitalizing on market opportunities.
Report Scope:
In this report, India atorvastatin market has
been segmented into following categories, in addition to the industry trends
which have also been detailed below:
- India Atorvastatin Market, By Source:
- In-House
- Contract
Manufacturing Organizations
- India Atorvastatin Market, By Form:
- India Atorvastatin Market, By Distribution Channel:
- India Atorvastatin Market, By Application:
- Hypercholesterolemia
- Hypertriglyceridemia
- Dyslipidaemia
- Others
- India Atorvastatin Market, By Region:
Competitive
Landscape
Company Profiles: Detailed analysis of the major
companies present in India atorvastatin market.
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following
customization options are available for the report:
Company Information
- Detailed analysis and
profiling of additional market players (up to five).
India atorvastatin market
is an upcoming report to be released soon. If you wish an early delivery of
this report or want to confirm the date of release, please contact us at [email protected]